KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Long-Term Deferred Tax (2016 - 2025)

Medpace Holdings' Long-Term Deferred Tax history spans 11 years, with the latest figure at $19.2 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 80.85% year-over-year to $19.2 million; the TTM value through Dec 2025 reached $19.2 million, down 80.85%, while the annual FY2025 figure was $19.2 million, 80.85% down from the prior year.
  • Long-Term Deferred Tax reached $19.2 million in Q4 2025 per MEDP's latest filing, down from $37.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $100.4 million in Q4 2024 to a low of $540000.0 in Q2 2021.
  • Average Long-Term Deferred Tax over 5 years is $46.9 million, with a median of $48.6 million recorded in 2022.
  • Peak YoY movement for Long-Term Deferred Tax: soared 4796.48% in 2022, then plummeted 80.85% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $25.1 million in 2021, then surged by 91.31% to $48.1 million in 2022, then soared by 54.81% to $74.4 million in 2023, then skyrocketed by 34.83% to $100.4 million in 2024, then tumbled by 80.85% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Long-Term Deferred Tax are $19.2 million (Q4 2025), $37.2 million (Q3 2025), and $65.8 million (Q2 2025).